Harry R. Trout III

Insider Reports History

Location
Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harry R. Trout III:

Company Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Vice President, Finance (Principal Financial Officer) Common Stock 16,348 $232,632 $14.23 05 Dec 2025 Direct
ENANTA PHARMACEUTICALS INC Vice President, Finance (Principal Financial Officer) Stock Option (right to buy) 12,925 25 Nov 2025 Direct

Insider Reports Filed by Harry R. Trout III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTA ENANTA PHARMACEUTICALS INC 05 Dec 2025 1 -$7,713 4 Vice President, Finance (Principal Financial Officer) 05 Dec 2025, 18:47
ENTA ENANTA PHARMACEUTICALS INC 01 Dec 2025 2 -$6,787 4 Vice President, Finance (Principal Financial Officer) 03 Dec 2025, 17:05
ENTA ENANTA PHARMACEUTICALS INC 25 Nov 2025 2 $0 4 Vice President, Finance (Principal Financial Officer) 26 Nov 2025, 17:20
ENTA ENANTA PHARMACEUTICALS INC 26 Aug 2025 0 $0 3 Vice President, Finance 08 Sep 2025, 18:00